Why BA/BE Studies
This section provides recommendations to the applicants, who undertake bioequivalence studies and/or who wish to request a waiver of in vivo bioequivalence studies for immediate release solid oral dosage forms. Guidance herein explains how the bioequivalence studies should be performed, and when biowaivers can be requested in the context of the WHO Prequalification of Medicines Programme.
Global BA/BE studies market is projected to increase to nearly $35.3 billion by 2015 from $31.5 billion in 2014. This market is expected to reach $46.8 billion by 2020, corresponding to a compound annual growth rate (CAGR) of 5.8% during 2015 to 2020 period.
- Analysis of BA/BE by oral vs parentral
- Criterion for bioequivalence confidence interval approach
- Parametric vs non-parametric tests
- Bioequivalence of endogenous substances
- Plasma concentration vs time curve (AUC) based dosing
- Adverse drug reactions
- In narrow therapeutic index drugs
Related Conference of Why BA/BE Studies
January 18-19 2016
International Conference on Drug Formulation Bioavailability and Pharmacy
London England
January 18-19 2016
International Conference on Pharmacology and Pharmaceutical Medicine
San Diego USA
January 18-19 2016
18th International Conference on Drug Formulation Bioavailability and Pharmacy
London UK
January 21-22 2016
International Conference on Pharmaceutical Sciences and Pharmacology
Paris France
January 24-28 2016
Drug Discovery for Parasitic Diseases
California USA
January 25-27 2016
5th Drug Formulation Bioavailability
Massachusetts USA
January 25-26 2016
International Conference on Drug Formulation Bioavailability and Pharmacological Sciences
Istanbul Turkey
January 27-28 2016
Summit on Biosimilars
Washington USA
Febraury 04-05 2016
International Conference on Drug Discovery and Designing
Melbourne Australia
February 10-11 2016
Biosimilar Drug Development World Europe
Barcelona Spain
February 11-12 2016
International Conference on Pharmacology and Biochemistry
Kuala Lumpur Malaysia
February 15-18 2016
7th International Conference on Drug Discovery and Therapy
Dubai UAE
February 21-24 2016
Structure Based Drug Design Conference
USA
February 25-26 2016
International Conference on Pharmacological Sciences
Dubai UAE
February 25-26 2016
International Conference on Pharmacology Medicinal and Pharmaceutical Sciences
London UK
March 2-3 2016
Clinical Trial Supply Europe Conference
Europe
March 30-31 2016
International Conference on Pharmaceutical Drugs and Drug Developments
Istanbul Turkey
March 9-12 2016
American Society for Clinical Pharmacology and Therapeutics ASCPT 2016 Annual Meeting
California USA
April 14-15 2016
6th Annual Drug Delivery Formulation Americas Summit
California USA
April 17 - 21 2016
Respiratory Drug Delivery 2016
Arizona USA
April 18-19 2016
Biosimilars Biobetters Congress
London UK
April 20-21 2016
11th Annual Fragment-Based Drug Discovery
California USA
May 24-25 2016
World Biosimilar Congress
San Diego USA
May 08-09 2016
International Conference on Pharmaceutical Drug Design Development and Technology
Dubai UAE
May 08-09 2016
International Conference on Drug Design Development and Clinical Pharmacy
Dubai UAE
May 12-13 2016
International Conference on Clinical Pharmacology and Drug Design
Amsterdam Netherlands
May 15-18 2016
Society for Clinical trails 37th Annual Meeting
Quebec Canada
May 17-18 2016
6th Annual Outsourcing in Clinical Trials Europe 2016
Paris France
May 18-19 2016
2nd Drug Delivery Strategy Advanced Mechanisms and Product Design
Philadelphia USA
May 23-24 2016
International Conference on Pharmacology Toxicology and Pharmaceutics
London UK
May 23-25 2016
7th Annual Global Drug Delivery Formulation Summit
Dusseldorf Germany
May 23-25 2016
7th annual global drug delivery formulation summit
Berlin Germany
May 25-26 2016
Outsourcing in Clinical Trials East Coast 2016
Pennsylvania USA
June 12-14 2016
6th Annual American drug delivery Formulation Summit
San Diego USA
June 13-15 2016
4th Annual conferences on European Pharma Congress
Germany
June 18-24 2016
Workshop on Methods in Clinical Cancer Research
Netherlands Europe
June 27-29 2016
3rd International Conference on Health Informatics and Technology
New Orleans USA
July 23-29 2016
Methods in Clinical Cancer Research Workshop
Vail Colorado
July 25-26 2016
International Conference on Medicinal Chemistry and Drug Design
Paris France
September 3-4 2016
FDA Clinical Trial Requirements Regulations Compliance and GCP Conference
San Diego USA
November 16-18 2016
27th Re-Entering Antibacterial Drug Development Summit
Boston USA
December 01-02 2016
International Conference on Pharmacology and Molecular Genetics Lagos
London UK
December 1-3 2016
5th Medicinal Chemistry Computer Aided Drug Designing Conference
Chicago USA
December 23-24 2015
International Conference on Pharmacology and Pharmaceutical Medicine
Dubai UAE
Why BA/BE Studies Conference Speakers
Recommended Sessions
- Bioequivalence Studies
- Advances in BABE
- Assessment of Bioequivalence
- Bioavailability Studies
- Bioequivalence Protocols : In vivo/ In vitro studies
- Biosimilars
- Challenges in Drug Design
- Challenges in Drug Development
- Clinical Pharmacology and Therapeutics
- Clinical Trials
- Contract Research Organizations
- Entrepreneur Investment Meet
- Factors Affecting Bioavailability
- Managing BA/BE Studies
- Nutrient Bioavailability
- Pharma Clinical Trials
- Regulatory Requirements for BE
- Study Designs
- Why BA/BE Studies